Diagnostic and Prognostic Value of Three microRNAs in Environmental Asbestiform Fibers-Associated Malignant Mesothelioma.

asbestos diagnosis fluoro-edenite malignant mesothelioma microRNA prognosis

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
15 Nov 2021
Historique:
received: 22 09 2021
revised: 08 11 2021
accepted: 11 11 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 28 11 2021
Statut: epublish

Résumé

Fluoro-edenite (FE) is an asbestiform fiber identified in Biancavilla (Sicily, Italy). Environmental exposure to FE has been associated with a higher incidence of malignant mesothelioma (MM). The present study aimed to validate the predicted diagnostic significance of hsa-miR-323a-3p, hsa-miR-101-3p, and hsa-miR-20b-5p on a subset of MM patients exposed to FE and matched with healthy controls. For this purpose, MM tissues vs. nonmalignant pleura tissues were analyzed through droplet digital PCR (ddPCR) to evaluate differences in the expression levels of the selected miRNAs and their MM diagnostic potential. In addition, further computational analysis has been performed to establish the correlation of these miRNAs with the available online asbestos exposure data and clinic-pathological parameters to verify the potential role of these miRNAs as prognostic tools. ddPCR results showed that the three analyzed miRNAs were significantly down-regulated in MM cases vs. controls. Receiver operating characteristic (ROC) analysis revealed high specificity and sensitivity rates for both hsa-miR-323a-3p and hsa-miR-20b-5p, which thus acquire a diagnostic value for MM. In silico results showed a potential prognostic role of hsa-miR-101-3p due to a significant association of its higher expression and increased overall survival (OS) of MM patients.

Identifiants

pubmed: 34834557
pii: jpm11111205
doi: 10.3390/jpm11111205
pmc: PMC8618926
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Lancet Oncol. 2014 Dec;15(13):1427-1428
pubmed: 25499275
J Thorac Dis. 2015 Jun;7(6):1031-40
pubmed: 26150916
Future Oncol. 2018 Mar;14(6s):53-57
pubmed: 29664355
Curr Mol Med. 2020;20(8):653-660
pubmed: 32077824
Lancet Oncol. 2013 Jun;14(7):576-8
pubmed: 23725699
Transl Lung Cancer Res. 2017 Jun;6(3):259-269
pubmed: 28713671
Arch Environ Health. 2003 Apr;58(4):229-32
pubmed: 14655903
Oncol Lett. 2015 May;9(5):2046-2052
pubmed: 26137010
Front Oncol. 2019 Aug 14;9:740
pubmed: 31475103
Histol Histopathol. 2006 Jun;21(6):595-601
pubmed: 16528669
Onco Targets Ther. 2017 Jul 24;10:3709-3718
pubmed: 28769574
Oncotarget. 2016 Sep 6;7(36):58606-58637
pubmed: 27259231
Cancers (Basel). 2019 Apr 30;11(5):
pubmed: 31052345
Am J Ind Med. 2012 Jan;55(1):11-24
pubmed: 22025020
Biosci Trends. 2017 Mar 22;11(1):105-109
pubmed: 28133000
Environ Res. 2016 Oct;150:23-29
pubmed: 27236568
Mol Med Rep. 2016 Nov;14(5):4467-4474
pubmed: 27748850
Int J Oncol. 2019 Jun;54(6):2139-2148
pubmed: 30942424
Arch Med Res. 2016 Jul;47(5):407
pubmed: 27751377
Dis Markers. 2013;35(2):119-27
pubmed: 24167356
Thorax. 2014 Oct;69(10):895-902
pubmed: 25037982
Cells. 2019 Oct 14;8(10):
pubmed: 31615102
Future Oncol. 2016 Dec;12(23s):59-62
pubmed: 27669761
Oncotarget. 2017 May 26;8(39):65240-65252
pubmed: 29029427
Aging (Albany NY). 2018 May 18;10(5):1000-1014
pubmed: 29779016
Toxicol In Vitro. 2003 Oct-Dec;17(5-6):547-52
pubmed: 14599443
Exp Mol Pathol. 2014 Dec;97(3):375-85
pubmed: 25236577
J Thorac Oncol. 2016 Feb;11(2):142-54
pubmed: 26811225
Lung Cancer. 2017 May;107:65-72
pubmed: 27312601
Oncol Lett. 2018 Dec;16(6):7048-7056
pubmed: 30546438
Nat Biotechnol. 2020 Jun;38(6):675-678
pubmed: 32444850
Cancer Biomark. 2018;22(1):127-133
pubmed: 29630525
Mol Med Rep. 2017 May;15(5):3372-3378
pubmed: 28339042
PLoS One. 2011 Feb 25;6(2):e17429
pubmed: 21364759
Scand J Work Environ Health. 2004 Jun;30(3):249-52
pubmed: 15250654
BMJ Open. 2014 Feb 24;4(2):e004145
pubmed: 24566531
Environ Res. 2016 May;147:97-101
pubmed: 26855127
Future Oncol. 2018 Mar;14(6s):59-62
pubmed: 29664352
Cancers (Basel). 2018 Jun 15;10(6):
pubmed: 29914087
Nucleic Acids Res. 2018 Jan 4;46(D1):D360-D370
pubmed: 29194489
Cancers (Basel). 2020 Sep 08;12(9):
pubmed: 32911851
Ecotoxicol Environ Saf. 2020 Jul 15;198:110640
pubmed: 32330788
J Immunotoxicol. 2018 Dec;15(1):24-28
pubmed: 29241379
Biomed Rep. 2020 Dec;13(6):60
pubmed: 33149905
Eur J Histochem. 2020 Apr 16;64(2):
pubmed: 32312030
Curr Treat Options Oncol. 2008 Jun;9(2-3):147-57
pubmed: 18709470
Arch Environ Health. 2000 Nov-Dec;55(6):392-8
pubmed: 11128876
Biology (Basel). 2020 Nov 06;9(11):
pubmed: 33172167
Oncotarget. 2017 Jul 18;8(29):48248-48252
pubmed: 28525386
Int J Mol Sci. 2018 Feb 28;19(3):
pubmed: 29495596
Ann Clin Biochem. 2018 Jan;55(1):49-58
pubmed: 29058958
Front Pharmacol. 2018 Aug 14;9:856
pubmed: 30154717
Oncotarget. 2016 Aug 2;7(31):50417-50427
pubmed: 27391431
Oncol Rep. 2019 Sep;42(3):911-922
pubmed: 31322245
Oncol Lett. 2016 Feb;11(2):1021-1025
pubmed: 26893685
Oncol Lett. 2016 Nov;12(5):3363-3367
pubmed: 27900005
Environ Health Perspect. 2015 May;123(5):399-411
pubmed: 25616258
Cancer Immunol Immunother. 2021 Jan;70(1):137-151
pubmed: 32653938

Auteurs

Veronica Filetti (V)

Human Anatomy and Histology, Department of Biomedical and Biotechnology Sciences, University of Catania, 95123 Catania, Italy.

Carla Loreto (C)

Human Anatomy and Histology, Department of Biomedical and Biotechnology Sciences, University of Catania, 95123 Catania, Italy.

Luca Falzone (L)

Epidemiology Unit, IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale", 80131 Naples, Italy.

Claudia Lombardo (C)

Human Anatomy, Department of Medical and Surgical Sciences and Advanced Technologies, University of Catania, 95123 Catania, Italy.

Emanuele Cannizzaro (E)

Occupational Medicine, Department of Sciences for Health Promotion and Mother and Child Care, University of Palermo, 90128 Palermo, Italy.

Sergio Castorina (S)

Human Anatomy, Department of Medical and Surgical Sciences and Advanced Technologies, University of Catania, 95123 Catania, Italy.

Caterina Ledda (C)

Occupational Medicine, Department of Clinical and Experimental Medicine, University of Catania, Via Santa Sofia 87, 95123 Catania, Italy.

Venerando Rapisarda (V)

Occupational Medicine, Department of Clinical and Experimental Medicine, University of Catania, Via Santa Sofia 87, 95123 Catania, Italy.

Classifications MeSH